Certara Announces D360 25.5 Release, Featuring Dynamic Data Subsets and Enhanced Analytics Announcement Certara Announces D360 25.5 Release, Featuring Dynamic Data Subsets and Enhanced Analytics D360 v25.5 allows scientists to divide up a dataset into series of compounds & perform…CertaraAugust 7, 2025
AusBiotech International Conference 2025 Conference AusBiotech International Conference 2025 Danielle PillsburyJuly 25, 2025
ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered Blog ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered ADNCA is transforming non-compartmental analysis by standardizing workflows, enhancing regulatory confidence, and enabling scalable automation.…CertaraJuly 23, 2025
Building PK/PD Workflows with Cloud and AI – APAC Webinar Webinar Building PK/PD Workflows with Cloud and AI – APAC Webinar CertaraJuly 15, 2025
Phoenix Roadshow 2025 – Copenhagen Live Events Phoenix Roadshow 2025 – Copenhagen CertaraJuly 2, 2025
The Reference-scaled Average Bioequivalence (RSABE) Approach Blog The Reference-scaled Average Bioequivalence (RSABE) Approach We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…CertaraJuly 1, 2025
Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1 Announcement Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1 Radnor, PA – June 20, 2025 - Certara, Inc. (Nasdaq: CERT), a global leader in…Danielle PillsburyJune 20, 2025
Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power Announcement Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power June 16, 2025 RADNOR, PA – June 16, 2025 – Certara, Inc. (Nasdaq: CERT), a…CertaraJune 16, 2025
Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis On-Demand Webinar Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis CertaraJune 11, 2025
Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer Publication Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…CertaraJune 8, 2025